Abstract
Background and Aims: Triggering receptor expressed on myeloid cells 2 (TREM2) is a lipid-sensing receptor involved in the regulation of several key myeloid cell functions, including proliferation, survival and phagocytosis. TREM2 is highly expressed on a subset of atherosclerosis-associated aortic macrophages, which express genes associated with lipid metabolism, oxidative stress and calcification while downregulating pro-inflammatory genes. These macrophages correspond to foamy macrophages, which are important players in atherogenesis. Therefore, we sought to investigate the effect of TREM2 deficiency on atherosclerosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
